What is the Return on Assets (ROA) of Li Kang Biomedical Co this year?
The Return on Assets (ROA) of Li Kang Biomedical Co is 0.13 undefined this year.
Li Kang Biomedical Co ROA 2024
Li Kang Biomedical Co ROA
0.13
Li Kang Biomedical Co Dividend yield
3.44 %
Ticker
6242.TWO
ISIN
TW0006242001
In 2024, Li Kang Biomedical Co's return on assets (ROA) was 0.13, a -17.52% increase from the 0.16 ROA in the previous year.
Li Kang Biomedical Co Aktienanalyse
What does Li Kang Biomedical Co do?
Li Kang Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Li Kang Biomedical Co's Return on Assets (ROA)
Li Kang Biomedical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Li Kang Biomedical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Li Kang Biomedical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Li Kang Biomedical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Li Kang Biomedical Co Stock
What was the ROA of Li Kang Biomedical Co compared to the previous year?
The ROA of Li Kang Biomedical Co has increased by -17.52% compared to the previous year.
What consequences do high ROA have for investors of Li Kang Biomedical Co?
A high ROA is advantageous for investors of Li Kang Biomedical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Li Kang Biomedical Co?
A low ROA can be unfavorable for investors of Li Kang Biomedical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Li Kang Biomedical Co affect the company?
An increase in ROA of Li Kang Biomedical Co can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Li Kang Biomedical Co impact the company?
A reduction in the ROA of Li Kang Biomedical Co can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Li Kang Biomedical Co?
Some factors that can influence the ROA of Li Kang Biomedical Co include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Li Kang Biomedical Co important for investors?
The ROA of Li Kang Biomedical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Li Kang Biomedical Co take to improve ROA?
To improve ROA, Li Kang Biomedical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Li Kang Biomedical Co pay?
Over the past 12 months, Li Kang Biomedical Co paid a dividend of 1.74 TWD . This corresponds to a dividend yield of about 3.44 %. For the coming 12 months, Li Kang Biomedical Co is expected to pay a dividend of 1.74 TWD.
What is the dividend yield of Li Kang Biomedical Co?
The current dividend yield of Li Kang Biomedical Co is 3.44 %.
When does Li Kang Biomedical Co pay dividends?
Li Kang Biomedical Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Li Kang Biomedical Co?
Li Kang Biomedical Co paid dividends every year for the past 2 years.
What is the dividend of Li Kang Biomedical Co?
For the upcoming 12 months, dividends amounting to 1.74 TWD are expected. This corresponds to a dividend yield of 3.44 %.
In which sector is Li Kang Biomedical Co located?
Li Kang Biomedical Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Li Kang Biomedical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Li Kang Biomedical Co from 8/7/2023 amounting to 1.739 TWD, you needed to have the stock in your portfolio before the ex-date on 6/30/2023.
When did Li Kang Biomedical Co pay the last dividend?
The last dividend was paid out on 8/7/2023.
What was the dividend of Li Kang Biomedical Co in the year 2023?
In the year 2023, Li Kang Biomedical Co distributed 1.242 TWD as dividends.
In which currency does Li Kang Biomedical Co pay out the dividend?
The dividends of Li Kang Biomedical Co are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Li Kang Biomedical Co
Our stock analysis for Li Kang Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Li Kang Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Li Kang Biomedical Co Revenue
- Li Kang Biomedical Co Net Income
- Li Kang Biomedical Co P/E
- Li Kang Biomedical Co P/S
- Li Kang Biomedical Co EBIT
- Li Kang Biomedical Co Dividend
- Li Kang Biomedical Co Stocks
- Li Kang Biomedical Co Market capitalization
- Li Kang Biomedical Co Debt
- Li Kang Biomedical Co Liabilities
- Li Kang Biomedical Co Equity
- Li Kang Biomedical Co AAQS
- Li Kang Biomedical Co Employees
- Li Kang Biomedical Co ROE
- Li Kang Biomedical Co ROA
- Li Kang Biomedical Co ROCE